Articles

Expert consensus

10.4244/EIJ-D-24-00954 Jun 2, 2025
A new implanter classification system for left atrial appendage closure from the European Left Atrial Appendage Closure Club (ELAACC)
Nielsen-Kudsk J, Aminian A, Backer O, Iriart X, Berti S, Galea R, Freixa X, Räber L, Cruz-González I, Wunderlich N, Garot P
free

Original Research

10.4244/EIJ-D-24-00971 Jun 2, 2025
Impact of pericoronary adipose tissue attenuation on clinical outcomes after percutaneous coronary intervention
Naniwa S, Kawamori H, Toba T, Hiromasa T, Sugizaki Y, Sasaki S, Fujii H, Hamana T, Osumi Y, Yamamoto T, Iwane S, Sakamoto Y, Matsuhama K, Fukuishi Y, Tsunamoto H, Higuchi K, Okamoto H, Iwasaki M, Takaya T, Yamada S, Hirata K, Otake H
free

Original Research

10.4244/EIJ-D-24-00586 Jun 2, 2025
Five-year outcomes of a drug-coated polymer-free biolimus-eluting stent versus an ultrathin-strut biodegradable-polymer sirolimus-eluting stent
Jensen L, Jakobsen L, Eftekhari A, Ellert-Gregersen J, Støttrup N, Engstrøm T, Kahlert J, Freeman P, Veien K, Jensen R, Lassen J, Junker A, Christiansen E
free

Original Research

10.4244/EIJ-D-24-00763 Jun 2, 2025
Everolimus-eluting versus biolimus-eluting stents with biodegradable polymers in unselected patients undergoing percutaneous coronary intervention: five-year results of the randomised, non-inferiority SORT OUT VIII trial
Støttrup N, Christiansen E, Raungaard B, Kahlert J, Terkelsen C, Kristensen S, Thim T, Jakobsen L, Jensen R, Eftekhari A, Freeman P, Jensen S, Veien K, Jensen L, Maeng M, for Randomized Trials with Clinical Outcome (SORT OUT) ftSO
free

Editorial

10.4244/EIJ-E-25-00015 May 16, 2025
Ticagrelor-based antiplatelet therapy after percutaneous coronary intervention in chronic coronary syndrome
Watanabe H, Kimura T
free

Viewpoint

10.4244/EIJ-E-25-00017 May 16, 2025
Restoring Europe's global position in medical device innovation
Gilard M, Prendergast B, Wijns W, Baumbach A, Maisano F, of the PCR Board o
free

State-of-the-Art

10.4244/EIJ-D-23-00915 May 16, 2025
Treatment of patent foramen ovale
Pristipino C, Carroll J, Mas J, Wunderlich N, Søndergaard L
free

Expert Review

10.4244/EIJ-D-24-00972 May 16, 2025
Leaflet modification techniques to mitigate coronary obstruction risk during transcatheter aortic valve implantation
Goel S, Tanner R, Chan K, Khan J, Vinayak M, Lerakis S, Safi L, Khera S, Krishnamoorthy P, Kini A, Sharma S, Dangas G, Tang G
free

Original Research

10.4244/EIJ-D-24-00662 May 16, 2025
Long-term structural valve deterioration after TAVI: insights from the EORP ESC Valve Durability TAVI Registry
Giannini C, Capodanno D, Toth G, Windecker S, Schüpke S, Blackman D, Noble S, Eltchaninoff H, Fiorina C, Chieffo A, Bartorelli A, Schmidt A, De Backer O, Gilard M, Curtis E, L’Official G, Donal E, Laroche C, Prendergast B, Petronio A, the European Valve Durability TAVI Registry investigators o
free

Original Research

10.4244/EIJ-D-24-00973 May 16, 2025
Ticagrelor monotherapy versus ticagrelor plus aspirin in patients with chronic coronary syndrome and high ischaemic risk: a post hoc analysis of the TWILIGHT trial
Gitto M, Baber U, Sartori S, Vogel B, Angiolillo D, Briguori C, Cohen D, Collier T, Dudek D, Oliva A, Escaned J, Feng Y, Gibson C, Han Y, Di Muro F, Shlofmitz R, Huber K, Steg P, Sharma S, Sardella G, Kastrati A, Kaul U, Kornowski R, Kunadian V, Stefanini G, Mehta S, Dangas G, Mehran R
free

Original Research

10.4244/EIJ-D-24-00757 May 16, 2025
Pharmacodynamic effects of cangrelor in patients with acute or chronic coronary syndrome undergoing percutaneous coronary intervention: the POMPEII Registry
Gargiulo G, Cirillo P, Sperandeo L, Castiello D, Manzi L, Forzano I, Florimonte D, Simonetti F, Canonico M, Avvedimento M, Paolillo R, Spinelli A, Buongiorno F, Serafino L, Spaccarotella CAM, Franzone A, Piccolo R, Stabile E, Valgimigli M, Esposito G
free

Trial Design

10.4244/EIJ-D-24-00829 May 16, 2025
Prasugrel monotherapy versus standard DAPT in STEMI patients with OCT-guided or angio-guided complete revascularisation: design and rationale of the randomised, multifactorial COMPARE STEMI ONE trial
Paradies V, Van Mieghem N, Oemrawsingh R, Richardt G, Esposito G, Campo G, Burzotta F, Canova P, Linke A, Porto I, Trabattoni D, Teeuwen K, Adriaenssens T, Kala P, Stankovic G, Vliet R, Giacoppo D, Daemen J, Smits P
free
Receive our newsletter


PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved